S-Space

Browse

Author

Showing results 1 to 3 of 3

Issue Date	Title / Author(s) / Citation	File
2013-06	Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905) Kim, H. R.; Jung, K. H.; Im, S. -A.; Im, Y. -H.; Kang, S. Y.; Park, K. H.; Lee, S.; Kim, S. -B.; Lee, K. -H.; Ahn, J. S.; Kim, S. I.; Sohn, J. H. Annals of Oncology, Vol.24 No.6, pp.1485-1490	DOI
2017-02	Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial Lee, Se-Hoon; Lee, J. -K.; Ahn, M. -J.; Kim, D. -W.; Sun, J. -M.; Keam, B.; Kim, T. M.; Heo, D. S.; Ahn, J. S.; Choi, Y. -L.; Min, H. -S.; Jeon, Y. K.; Park, K. Annals of Oncology, Vol.28 No.2, pp.292-297	DOI
2020-08	Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study Mok, T.; Camidge, D. R.; Gadgeel, S. M.; Rosell, R.; Dziadziuszko, R.; Kim, D-W; Perol, M.; Ou, S-H, I; Ahn, J. S.; Shaw, A. T.; Bordogna, W.; Smoljanovic, V; Hilton, M.; Ruf, T.; Noe, J.; Peters, S. Annals of Oncology, Vol.31 No.8, pp.1056-1064	DOI